Activity remains stock specific on the Indian bourses this morning, with investors continuing to track quarterly earnings results. The Sensex is down 6.10 points or 0.02% at 26,081.32. The Nifty is at 7785.90, down 5.50 points or 0.07 percent from previous ... Sify, 2 months ago
Sensex up nearly 200 pts as stocks open on buoyant note - Sify, 3 days ago
Indian Stock Market Updates By Stock Tips Provider - Press Release Ping, 4 days ago
1 images for "cipla india"
Hero, Tata Motors, Bajaj Auto, BHEL and Cipla are top gainers while ONGC, Coal India, Tata Power, SBI and ITC are laggards.Money Control, 3 days ago Sensex, Nifty flat; Sesa Sterlite, NTPC, Hindalco gainers Money Control, 4 days ago Weak global cues drag Sensex, Nifty; Coal India, JSPL fall Money Control, 4 weeks ago Market bleeds: Sensex plunges 431 pts, Nifty below 8050 Money Control, 1 month ago
Cipla closed down 1.6% at Rs. 610, while Coal India closed down 1.26% at Rs. 340 on BSE. The BSE Sensex closed at 26,631 up 138 points on Wednesday , while NSE Nifty closed at 7,975 up 42 points over the previous close. On the BSE, 1533 stocks advanced ...India Infoline, 1 month ago Coal India shines on BSE, up 1.5% Hindu Business Line, 1 week ago
Indian equities continuedto trade loweron Monday trackingweak global cues. At 11.29 a.m., the Sensex was trading down 126.16 points or 0.48% at 26,171.22 with 23 components falling. Meanwhile, the Nifty was trading lower by 42.30 points or 0.54% at ...New Indian Express, 1 week ago
Sun Pharma, TCS, BHEL, Infosys and Cipla are top gainers while Hindalco, HUL, Tata Power, Coal India and ITC are among the laggards in the Sensex.Money Control, 3 weeks ago Sensex, Nifty in consolidation mode; banks metals drag Money Control, 3 weeks ago Cautious trade drags Sensex, Nifty; Sun Pharma falls Money Control, 1 month ago Sensex, Nifty volatile ahead of CPI, IIP; ITC, Maruti up 1% Money Control, 1 month ago
Cipla Ltd has informed BSE that India Ratings Research Private Limited, a Fitch Group Company have affirmed the Long-Term Issuer Rating of IND AAA to the Company and IND A1+ rating to the Company's Rs 10 billion Commercial Paper/Short Term Debt Programme.Money Control, 2 weeks ago India Ratings affirms Cipla's long-term issuer rating at 'AAA' Indian-Commodity, 2 weeks ago Ind-Ra affirms Cipla's ratings at 'AAA' MyIris, 2 weeks ago
SBI | Coal India | Hindalco Industries | JSW Energy | Cipla | Jaiprakash Power Ventures | Adani Power | JK Tyre | City Union Bank | Bajaj Hindusthan | Jaiprakash Associates | Sharda Cropchem | Sadbhav Engineering | PFC | India Cements | MCX India | Financial ...Money Control, 4 weeks ago Nifty drags below 8000 on FO expiry day, Sensex weak Money Control, 1 month ago Sensex sheds 114 points ahead of F&O expiry; metal, power stocks trip MSN India, 1 month ago Sensex, Nifty flat; Coal India SBI up, JP Power falls 5% Money Control, 1 month ago
India-based drug maker Cipla's Medpro Pharmaceutica has collaborated with Israel's Teva Pharmaceuticals to provide South Africans with access to a broader range of affordable medicines. The latest partnership is a sales and distribution ...Pharmaceutical Business Review, 2 weeks ago Cipla signs pact with Teva for selling drugs in South Africa The Statesman, 2 weeks ago Cipla Medpro announces collaboration with world's largest generic pharmaceutical company FirstWord Pharma, 2 weeks ago Prefer Cipla, Cadilla Healthcare: Sandeep Bhatia Moneycontrol.com, 1 month ago
More from: , Rediff.com...and 1 other sources
Infosys | Tata Motors | Maruti Suzuki | TVS Motor | Cipla | Ashok Leyland | Gail India | IFCI | GMR Infrastructure | NTPC | Bharti Airtel | GVK Power | Idea Cellular | Raymond | Godrej Consumer Products | Ranbaxy Labs | Apollo Tyres | SCI | Wonderla | ...Money Control, 2 weeks ago Stocks in news: Tata Motors, GTL Infra, ICICI, Cipla, SPML Money Control, 1 month ago Stocks in news: Tata Motors, TVS Motor, Cipla, REC, PFC Money Control, 1 month ago Stocks in news: ONGC, Tata Steel, Nalco, Voltas, Lanco, MCX Money Control, 2 months ago
Seven India-based firms - Ranbaxy, Cipla, Mylan, Cadila, Hetero, Sequent and Strides Arcolab - will produce hepatitis C medicines for distribution in 91 developing countries BS B2B Bureau | New Delhi September 17, 2014 Last Updated at 13:18 IST In what could ...Business Standard, 1 month ago Gilead Sciences picks India to lower drug cost Asian Age, 1 month ago Gilead licenses hepatitis C drugs to 7 India-based pharma cos Business Standard, 1 month ago Gilead licenses hepatitis C drug to Cipla, Ranbaxy, five others Business Standard, 1 month ago
on your WebpageAdd Widget >Get your members hooked!